Is Symbiox Investme overvalued or undervalued?
As of June 27, 2025, Symbiox Investme is considered undervalued with a PE ratio of 8.67 and a Price to Book Value of 0.27, significantly lower than peers in the Non-Banking Financial Company sector, despite its stock underperforming the Sensex with a return of -48.89%.
As of 27 June 2025, the valuation grade for Symbiox Investme has moved from expensive to fair. The company is currently assessed as undervalued. Key ratios include a PE ratio of 8.67, a Price to Book Value of 0.27, and a PEG ratio of 0.05, indicating a low valuation compared to its earnings growth potential.In comparison with peers, Life Insurance has a PE ratio of 12.53 and an EV to EBITDA of 9.88, while I R F C shows a PE of 28.13 and an EV to EBITDA of 21.81. These comparisons further highlight Symbiox Investme's relative undervaluation within the Non-Banking Financial Company (NBFC) sector. Notably, the company's stock has underperformed against the Sensex in the year-to-date period, with a return of -48.89% compared to the Sensex's 7.58%, reinforcing the perception of undervaluation.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
